Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings



Rating:

Share or cite this content

Citations should be made in the following way:
B. Vanaudenaerde, R. Vos, A. Ottevaere, S. De Vleeschauwer, A. Willems-Widyastuti, D. Van raemdonck, L. Dupont, G. Verleden (Leuven, Belgium). A retrospective analysis of our lung transplant cohort for the dichotomy within bronchiolitis obliterans syndrome and azithromycin therapy. Eur Respir J 2009; 34: Suppl. 53, 2240

Member's Comments

No comment yet.

Related content which might interest you: A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation Source: ERJ Open Res, 5 (4) 00167-2019; 10.1183/23120541.00167-2019 Year: 2019 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 BAL neutrophil levels in a randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome post lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 177s Year: 2004 Comprehensive pulmonary rehabilitation in patients with bronchiolitis obliterans syndrome: A case series Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004 Treatment options in patients with bronchiolitis obliterans syndrome Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Multiple breath washout in bronchiolitis obliterans syndrome following paediatric lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Azithromycin and bronchiolitis obliterans syndrome after lung transplantation: is prevention better than cure? Source: Eur Respir J 2011; 37: 10-12 Year: 2011 The incidence of bronchiolitis obliterans organizing pneumonia syndrome after radiation therapy for breast cancer Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 Idiopathic chronic obliterative bronchiolitis: a multicentric retrospective cohort Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Pulmonary function and clinical outcome of patients with post-infectious bronchiolitis obliterans (BO) Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004 Clinical and biological effects of chronic low dose azythromycin treatment in patients with bronchiolitis obliterans Source: Eur Respir J 2007; 30: Suppl. 51, 517s Year: 2007 Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003